Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2011-08

AUTHORS

Luigi Celio, Sergio Frustaci, Angela Denaro, Angela Buonadonna, Antonio Ardizzoia, Elena Piazza, Alessandra Fabi, Alba Maria Capobianco, Luciano Isa, Luigi Cavanna, Alessandro Bertolini, Ettore Bichisao, Emilio Bajetta,

ABSTRACT

PURPOSE: A phase III trial assessed the efficacy of palonosetron plus dexamethasone given once in preventing acute and delayed chemotherapy-induced nausea and vomiting (CINV) following a broad range of moderately emetogenic chemotherapy (MEC) regimens. METHODS: This multicentre, randomized, open-label, non-inferiority trial evaluated two different treatment groups. One group received palonosetron (0.25 mg intravenously) and dexamethasone (8 mg intravenously) before chemotherapy, while the other was administered the same regimen on day 1 followed by dexamethasone 8 mg orally on days 2 and 3. The primary endpoint was complete response (CR; defined as no emetic episodes and no rescue medication) during the overall phase (days 1-5 after chemotherapy initiation). The non-inferiority margin was predefined as a 15% difference between groups in the primary endpoint. RESULTS: Of 332 chemotherapy-naïve patients included in the intention-to-treat analysis, 65.1% were female, and 35.2% received anthracycline plus cyclophosphamide (AC)-based regimens. Overall CR rates were 67.5% for those administered dexamethasone only on day 1 (n = 166), and 71.1% for those also administered dexamethasone on days 2 and 3 (n = 166; difference -3.6% (95% confidence interval, -13.5 to 6.3)). CR rates were not significantly different between groups during the acute (0-24 h post-chemotherapy; 88.6% versus 84.3%; P = 0.262) and delayed phases (days 2-5; 68.7% versus 77.7%; P = 0.116). CONCLUSIONS: Palonosetron plus single-dose dexamethasone administered before common MEC regimens provide protection against acute and delayed CINV which is non-inferior to that of palonosetron plus dexamethasone for 3 days. However, the major benefit of the single-day regimen occurs in patients receiving non-AC MEC regimens. More... »

PAGES

1217-1225

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00520-010-0941-7

DOI

http://dx.doi.org/10.1007/s00520-010-0941-7

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1016127884

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/20574663


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anthracyclines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents, Hormonal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chi-Square Distribution", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Confidence Intervals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dexamethasone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug-Related Side Effects and Adverse Reactions", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Health Status Indicators", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Isoquinolines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Multivariate Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nausea", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Quinuclidines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Assessment", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Serotonin Antagonists", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vomiting", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Istituto Nazionale dei Tumori", 
          "id": "https://www.grid.ac/institutes/grid.417893.0", 
          "name": [
            "Medical Oncology Unit 2, Fondazione IRCCS \u201cIstituto Nazionale dei Tumori\u201d, Via Venezian 1, 20133 Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Celio", 
        "givenName": "Luigi", 
        "id": "sg:person.01270617624.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01270617624.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centro di Riferimento Oncologico", 
          "id": "https://www.grid.ac/institutes/grid.418321.d", 
          "name": [
            "Centro di Riferimento Oncologico, Via Gallini 2, 33081 Aviano, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Frustaci", 
        "givenName": "Sergio", 
        "id": "sg:person.0652421767.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0652421767.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Nazionale dei Tumori", 
          "id": "https://www.grid.ac/institutes/grid.417893.0", 
          "name": [
            "Medical Oncology Unit 2, Fondazione IRCCS \u201cIstituto Nazionale dei Tumori\u201d, Via Venezian 1, 20133 Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Denaro", 
        "givenName": "Angela", 
        "id": "sg:person.01050706177.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050706177.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centro di Riferimento Oncologico", 
          "id": "https://www.grid.ac/institutes/grid.418321.d", 
          "name": [
            "Centro di Riferimento Oncologico, Via Gallini 2, 33081 Aviano, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Buonadonna", 
        "givenName": "Angela", 
        "id": "sg:person.01226564066.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01226564066.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Azienda Ospedaliera San Gerardo", 
          "id": "https://www.grid.ac/institutes/grid.415025.7", 
          "name": [
            "Ospedale San Gerardo, Via Pergolesi 33, 20052 Monza, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ardizzoia", 
        "givenName": "Antonio", 
        "id": "sg:person.01207036636.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01207036636.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Luigi Sacco Hospital", 
          "id": "https://www.grid.ac/institutes/grid.144767.7", 
          "name": [
            "Ospedale L. Sacco, Via Grassi 74, 20157 Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Piazza", 
        "givenName": "Elena", 
        "id": "sg:person.01336710567.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01336710567.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituti Fisioterapici Ospitalieri", 
          "id": "https://www.grid.ac/institutes/grid.417520.5", 
          "name": [
            "Istituto Regina Elena, Via Chianesi 53, 00144 Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fabi", 
        "givenName": "Alessandra", 
        "id": "sg:person.0635337452.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0635337452.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centro di Riferimento Oncologico della Basilicata", 
          "id": "https://www.grid.ac/institutes/grid.418322.e", 
          "name": [
            "Centro Riferimento Oncologico della Basilicata, Strada Provinciale n. 8 del Vulture, 85028 Rionero in Vulture, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Capobianco", 
        "givenName": "Alba Maria", 
        "id": "sg:person.01313436706.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01313436706.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Ospedale Serbelloni, Via Bellini 5, 20064 Gorgonzola, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Isa", 
        "givenName": "Luciano", 
        "id": "sg:person.01323422756.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01323422756.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Ospedale Guglielmo da Saliceto, Via Taverna 49, 29100 Piacenza, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cavanna", 
        "givenName": "Luigi", 
        "id": "sg:person.0771775231.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0771775231.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Ospedale di Sondrio, Via Stelvio 25, 23100 Sondrio, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bertolini", 
        "givenName": "Alessandro", 
        "id": "sg:person.0636427656.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0636427656.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "ITMO operative office, Via Ponzio 44, 20133 Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bichisao", 
        "givenName": "Ettore", 
        "id": "sg:person.01251771615.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01251771615.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Nazionale dei Tumori", 
          "id": "https://www.grid.ac/institutes/grid.417893.0", 
          "name": [
            "Medical Oncology Unit 2, Fondazione IRCCS \u201cIstituto Nazionale dei Tumori\u201d, Via Venezian 1, 20133 Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bajetta", 
        "givenName": "Emilio", 
        "id": "sg:person.01075001254.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01075001254.33"
        ], 
        "type": "Person"
      }, 
      {}
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1093/annonc/mdj936", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001372120"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdj944", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002400172"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdp584", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007050927"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00520-004-0700-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008308814", 
          "https://doi.org/10.1007/s00520-004-0700-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.11817", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010335838"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2007.15.9533", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010850821"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdj078", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011961022"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00520-008-0535-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015303642", 
          "https://doi.org/10.1007/s00520-008-0535-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00520-008-0535-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015303642", 
          "https://doi.org/10.1007/s00520-008-0535-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6603048", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030164430", 
          "https://doi.org/10.1038/sj.bjc.6603048"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6603048", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030164430", 
          "https://doi.org/10.1038/sj.bjc.6603048"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.09.050", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031033192"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(05)01735-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034367406"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdl347", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037286350"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejcsup.2008.06.018", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037546665"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003495-200464100-00006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037955349", 
          "https://doi.org/10.2165/00003495-200464100-00006"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003495-200464100-00006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037955349", 
          "https://doi.org/10.2165/00003495-200464100-00006"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.04.022", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043661291"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmra0706547", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047566735"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdg417", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047729604"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1213/ane.0b013e318172fa74", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051586456"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1213/ane.0b013e318172fa74", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051586456"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1213/ane.0b013e318172fa74", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051586456"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2000.18.19.3409", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074706771"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077302236", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077317669", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1997.15.1.103", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083031468"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2011-08", 
    "datePublishedReg": "2011-08-01", 
    "description": "PURPOSE: A phase III trial assessed the efficacy of palonosetron plus dexamethasone given once in preventing acute and delayed chemotherapy-induced nausea and vomiting (CINV) following a broad range of moderately emetogenic chemotherapy (MEC) regimens.\nMETHODS: This multicentre, randomized, open-label, non-inferiority trial evaluated two different treatment groups. One group received palonosetron (0.25\u00a0mg intravenously) and dexamethasone (8\u00a0mg intravenously) before chemotherapy, while the other was administered the same regimen on day\u00a01 followed by dexamethasone 8\u00a0mg orally on days\u00a02 and 3. The primary endpoint was complete response (CR; defined as no emetic episodes and no rescue medication) during the overall phase (days\u00a01-5 after chemotherapy initiation). The non-inferiority margin was predefined as a 15% difference between groups in the primary endpoint.\nRESULTS: Of 332 chemotherapy-na\u00efve patients included in the intention-to-treat analysis, 65.1% were female, and 35.2% received anthracycline plus cyclophosphamide (AC)-based regimens. Overall CR rates were 67.5% for those administered dexamethasone only on day\u00a01 (n\u2009=\u2009166), and 71.1% for those also administered dexamethasone on days\u00a02 and 3 (n\u2009=\u2009166; difference -3.6% (95% confidence interval, -13.5 to 6.3)). CR rates were not significantly different between groups during the acute (0-24\u00a0h post-chemotherapy; 88.6% versus 84.3%; P\u2009=\u20090.262) and delayed phases (days\u00a02-5; 68.7% versus 77.7%; P\u2009=\u20090.116).\nCONCLUSIONS: Palonosetron plus single-dose dexamethasone administered before common MEC regimens provide protection against acute and delayed CINV which is non-inferior to that of palonosetron plus dexamethasone for 3\u00a0days. However, the major benefit of the single-day regimen occurs in patients receiving non-AC MEC regimens.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00520-010-0941-7", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1103473", 
        "issn": [
          "0941-4355", 
          "1433-7339"
        ], 
        "name": "Supportive Care in Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "8", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "19"
      }
    ], 
    "name": "Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial", 
    "pagination": "1217-1225", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "4cd86a5746f004c969b97ae24ffd43ffcc74818333b58fdb65de43f968c5e0ca"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "20574663"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9302957"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00520-010-0941-7"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1016127884"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00520-010-0941-7", 
      "https://app.dimensions.ai/details/publication/pub.1016127884"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T18:26", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8675_00000546.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128271/"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00520-010-0941-7'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00520-010-0941-7'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00520-010-0941-7'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00520-010-0941-7'


 

This table displays all metadata directly associated to this object as RDF triples.

330 TRIPLES      21 PREDICATES      72 URIs      42 LITERALS      30 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00520-010-0941-7 schema:about N0c65ce4abeb24df4ba1b3c037dac24da
2 N10fa5fa6eba841089fc36bb4132d2c9e
3 N1c70554e022c433ca17f23710e133988
4 N20acc13162b94b4abc8fd286421a6c16
5 N2608c610b1964fe09111f90c565bee08
6 N2ae771a1079b4d40b38d81748ac8b0a6
7 N40c27a923858465381d49c895efda514
8 N4182df0fb64345a1bb0f830388442b10
9 N4ce5e4b1db4341c7ae1b91857acd5c79
10 N5b3e81978dbd4c07bed5d5aa0f265f05
11 N632e91a10e3a4c0cbb2b44181620d709
12 N6764ef670a3c4b10897dff6508ad5bf5
13 N6eef464c0b1346e9bd16e82f3f37aecb
14 N7dfa58cf57624b0a8934427cf0173b3c
15 N8eff18a05b6d445a8d0739e5c76c383a
16 N9c0dfee5908149cd98edb119e7b2ded4
17 Nadd6dad439a44068bb67a7238a5ba466
18 Nc87b6f25297a41179eb6f9ebf15ce23b
19 Ncf8112f8b55e4ab8be616ece68851eb6
20 Nd33fb34214c54ef9bf63bb4d148b79da
21 Nf50f960552214f92b0d730fc7b53b936
22 anzsrc-for:11
23 anzsrc-for:1112
24 schema:author N1a86e9cbe729437f9eab16603d293a28
25 schema:citation sg:pub.10.1007/s00520-004-0700-8
26 sg:pub.10.1007/s00520-008-0535-9
27 sg:pub.10.1038/sj.bjc.6603048
28 sg:pub.10.2165/00003495-200464100-00006
29 https://app.dimensions.ai/details/publication/pub.1077302236
30 https://app.dimensions.ai/details/publication/pub.1077317669
31 https://doi.org/10.1002/cncr.11817
32 https://doi.org/10.1016/j.ejcsup.2008.06.018
33 https://doi.org/10.1016/s1470-2045(05)01735-3
34 https://doi.org/10.1056/nejmra0706547
35 https://doi.org/10.1093/annonc/mdg417
36 https://doi.org/10.1093/annonc/mdj078
37 https://doi.org/10.1093/annonc/mdj936
38 https://doi.org/10.1093/annonc/mdj944
39 https://doi.org/10.1093/annonc/mdl347
40 https://doi.org/10.1093/annonc/mdp584
41 https://doi.org/10.1200/jco.1997.15.1.103
42 https://doi.org/10.1200/jco.2000.18.19.3409
43 https://doi.org/10.1200/jco.2005.04.022
44 https://doi.org/10.1200/jco.2005.09.050
45 https://doi.org/10.1200/jco.2007.15.9533
46 https://doi.org/10.1213/ane.0b013e318172fa74
47 schema:datePublished 2011-08
48 schema:datePublishedReg 2011-08-01
49 schema:description PURPOSE: A phase III trial assessed the efficacy of palonosetron plus dexamethasone given once in preventing acute and delayed chemotherapy-induced nausea and vomiting (CINV) following a broad range of moderately emetogenic chemotherapy (MEC) regimens. METHODS: This multicentre, randomized, open-label, non-inferiority trial evaluated two different treatment groups. One group received palonosetron (0.25 mg intravenously) and dexamethasone (8 mg intravenously) before chemotherapy, while the other was administered the same regimen on day 1 followed by dexamethasone 8 mg orally on days 2 and 3. The primary endpoint was complete response (CR; defined as no emetic episodes and no rescue medication) during the overall phase (days 1-5 after chemotherapy initiation). The non-inferiority margin was predefined as a 15% difference between groups in the primary endpoint. RESULTS: Of 332 chemotherapy-naïve patients included in the intention-to-treat analysis, 65.1% were female, and 35.2% received anthracycline plus cyclophosphamide (AC)-based regimens. Overall CR rates were 67.5% for those administered dexamethasone only on day 1 (n = 166), and 71.1% for those also administered dexamethasone on days 2 and 3 (n = 166; difference -3.6% (95% confidence interval, -13.5 to 6.3)). CR rates were not significantly different between groups during the acute (0-24 h post-chemotherapy; 88.6% versus 84.3%; P = 0.262) and delayed phases (days 2-5; 68.7% versus 77.7%; P = 0.116). CONCLUSIONS: Palonosetron plus single-dose dexamethasone administered before common MEC regimens provide protection against acute and delayed CINV which is non-inferior to that of palonosetron plus dexamethasone for 3 days. However, the major benefit of the single-day regimen occurs in patients receiving non-AC MEC regimens.
50 schema:genre research_article
51 schema:inLanguage en
52 schema:isAccessibleForFree true
53 schema:isPartOf N5bd4661d29c3429083dad786d89aea69
54 Ne7a410a9162d467ca83327816ec50a00
55 sg:journal.1103473
56 schema:name Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial
57 schema:pagination 1217-1225
58 schema:productId N3312a7ecc3fb472b948964383115306a
59 N5235bab427f34ce8b085315d8063956e
60 N549062b0e62e48c1a55706ca9905aff4
61 N91cf7bbb7861425ba3df014f7a46c741
62 N9281227d79724758aa0ab95cd913b903
63 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016127884
64 https://doi.org/10.1007/s00520-010-0941-7
65 schema:sdDatePublished 2019-04-10T18:26
66 schema:sdLicense https://scigraph.springernature.com/explorer/license/
67 schema:sdPublisher Nc7a23726ca544a249cc13c9d93679237
68 schema:url http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128271/
69 sgo:license sg:explorer/license/
70 sgo:sdDataset articles
71 rdf:type schema:ScholarlyArticle
72 N0c65ce4abeb24df4ba1b3c037dac24da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name Middle Aged
74 rdf:type schema:DefinedTerm
75 N10fa5fa6eba841089fc36bb4132d2c9e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Confidence Intervals
77 rdf:type schema:DefinedTerm
78 N1a86e9cbe729437f9eab16603d293a28 rdf:first sg:person.01270617624.45
79 rdf:rest N2613335aeb9d45b78b31116a65dfcc24
80 N1c70554e022c433ca17f23710e133988 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Serotonin Antagonists
82 rdf:type schema:DefinedTerm
83 N20acc13162b94b4abc8fd286421a6c16 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Time Factors
85 rdf:type schema:DefinedTerm
86 N2608c610b1964fe09111f90c565bee08 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Anthracyclines
88 rdf:type schema:DefinedTerm
89 N2613335aeb9d45b78b31116a65dfcc24 rdf:first sg:person.0652421767.09
90 rdf:rest Ncfb1c3ad9ca741429346064bec441c45
91 N284cbb49a584473ab400fa7c595ce50c rdf:first sg:person.0636427656.94
92 rdf:rest Nf4d5998ded23439cb120ae3ec2ce9a5e
93 N2ae771a1079b4d40b38d81748ac8b0a6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Quinuclidines
95 rdf:type schema:DefinedTerm
96 N3312a7ecc3fb472b948964383115306a schema:name readcube_id
97 schema:value 4cd86a5746f004c969b97ae24ffd43ffcc74818333b58fdb65de43f968c5e0ca
98 rdf:type schema:PropertyValue
99 N40c27a923858465381d49c895efda514 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Chi-Square Distribution
101 rdf:type schema:DefinedTerm
102 N4182df0fb64345a1bb0f830388442b10 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Drug Therapy, Combination
104 rdf:type schema:DefinedTerm
105 N4926aeac1ec54c3586e34609a597a295 rdf:first sg:person.01323422756.41
106 rdf:rest Ne11291aa208b476eaebf6a0eabe8f637
107 N4ce5e4b1db4341c7ae1b91857acd5c79 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Health Status Indicators
109 rdf:type schema:DefinedTerm
110 N5235bab427f34ce8b085315d8063956e schema:name dimensions_id
111 schema:value pub.1016127884
112 rdf:type schema:PropertyValue
113 N549062b0e62e48c1a55706ca9905aff4 schema:name nlm_unique_id
114 schema:value 9302957
115 rdf:type schema:PropertyValue
116 N5b3e81978dbd4c07bed5d5aa0f265f05 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Male
118 rdf:type schema:DefinedTerm
119 N5bd4661d29c3429083dad786d89aea69 schema:issueNumber 8
120 rdf:type schema:PublicationIssue
121 N632e91a10e3a4c0cbb2b44181620d709 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Risk Assessment
123 rdf:type schema:DefinedTerm
124 N6764ef670a3c4b10897dff6508ad5bf5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Female
126 rdf:type schema:DefinedTerm
127 N6eef464c0b1346e9bd16e82f3f37aecb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Drug-Related Side Effects and Adverse Reactions
129 rdf:type schema:DefinedTerm
130 N786588e059664596a1d353b97038eeac rdf:first sg:person.01075001254.33
131 rdf:rest Nbfda149660dc4479813124e4499fd086
132 N7dfa58cf57624b0a8934427cf0173b3c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Antineoplastic Agents, Hormonal
134 rdf:type schema:DefinedTerm
135 N7f11b1a5a9e84e3994180ec368832fae schema:name Ospedale Guglielmo da Saliceto, Via Taverna 49, 29100 Piacenza, Italy
136 rdf:type schema:Organization
137 N888d1069721a491bb8ffd2281115ce95 schema:name ITMO operative office, Via Ponzio 44, 20133 Milan, Italy
138 rdf:type schema:Organization
139 N8eff18a05b6d445a8d0739e5c76c383a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Dexamethasone
141 rdf:type schema:DefinedTerm
142 N91cf7bbb7861425ba3df014f7a46c741 schema:name doi
143 schema:value 10.1007/s00520-010-0941-7
144 rdf:type schema:PropertyValue
145 N9281227d79724758aa0ab95cd913b903 schema:name pubmed_id
146 schema:value 20574663
147 rdf:type schema:PropertyValue
148 N94476a5b3af44d56bdc441c9049bca8a rdf:first sg:person.0635337452.63
149 rdf:rest Neaa62489da6e425dbb2ec5efaeeb4c4e
150 N9c0dfee5908149cd98edb119e7b2ded4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Multivariate Analysis
152 rdf:type schema:DefinedTerm
153 Naa24ed4bc82c4efc94c2b60df54e4692 rdf:first sg:person.01226564066.51
154 rdf:rest Nb2a2bcef53554d4d9222363af6bb97ae
155 Nadd6dad439a44068bb67a7238a5ba466 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Nausea
157 rdf:type schema:DefinedTerm
158 Nb2a2bcef53554d4d9222363af6bb97ae rdf:first sg:person.01207036636.03
159 rdf:rest Nf9d4f6fe912b491aaf8781b83b2cdde3
160 Nbfda149660dc4479813124e4499fd086 rdf:first N82b0c57af92f4154aa9e40049c592265
161 rdf:rest rdf:nil
162 Nc7a23726ca544a249cc13c9d93679237 schema:name Springer Nature - SN SciGraph project
163 rdf:type schema:Organization
164 Nc87b6f25297a41179eb6f9ebf15ce23b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Humans
166 rdf:type schema:DefinedTerm
167 Ncf8112f8b55e4ab8be616ece68851eb6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Aged
169 rdf:type schema:DefinedTerm
170 Ncfb1c3ad9ca741429346064bec441c45 rdf:first sg:person.01050706177.10
171 rdf:rest Naa24ed4bc82c4efc94c2b60df54e4692
172 Nd33fb34214c54ef9bf63bb4d148b79da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Isoquinolines
174 rdf:type schema:DefinedTerm
175 Ne11291aa208b476eaebf6a0eabe8f637 rdf:first sg:person.0771775231.11
176 rdf:rest N284cbb49a584473ab400fa7c595ce50c
177 Ne7a410a9162d467ca83327816ec50a00 schema:volumeNumber 19
178 rdf:type schema:PublicationVolume
179 Neaa62489da6e425dbb2ec5efaeeb4c4e rdf:first sg:person.01313436706.49
180 rdf:rest N4926aeac1ec54c3586e34609a597a295
181 Nf0c0e5f099a344b698b97dd8c33d6b72 schema:name Ospedale Serbelloni, Via Bellini 5, 20064 Gorgonzola, Italy
182 rdf:type schema:Organization
183 Nf4d5998ded23439cb120ae3ec2ce9a5e rdf:first sg:person.01251771615.34
184 rdf:rest N786588e059664596a1d353b97038eeac
185 Nf50f960552214f92b0d730fc7b53b936 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
186 schema:name Vomiting
187 rdf:type schema:DefinedTerm
188 Nf59eb66b3c814c0a8957de869ccbdce1 schema:name Ospedale di Sondrio, Via Stelvio 25, 23100 Sondrio, Italy
189 rdf:type schema:Organization
190 Nf9d4f6fe912b491aaf8781b83b2cdde3 rdf:first sg:person.01336710567.12
191 rdf:rest N94476a5b3af44d56bdc441c9049bca8a
192 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
193 schema:name Medical and Health Sciences
194 rdf:type schema:DefinedTerm
195 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
196 schema:name Oncology and Carcinogenesis
197 rdf:type schema:DefinedTerm
198 sg:journal.1103473 schema:issn 0941-4355
199 1433-7339
200 schema:name Supportive Care in Cancer
201 rdf:type schema:Periodical
202 sg:person.01050706177.10 schema:affiliation https://www.grid.ac/institutes/grid.417893.0
203 schema:familyName Denaro
204 schema:givenName Angela
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050706177.10
206 rdf:type schema:Person
207 sg:person.01075001254.33 schema:affiliation https://www.grid.ac/institutes/grid.417893.0
208 schema:familyName Bajetta
209 schema:givenName Emilio
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01075001254.33
211 rdf:type schema:Person
212 sg:person.01207036636.03 schema:affiliation https://www.grid.ac/institutes/grid.415025.7
213 schema:familyName Ardizzoia
214 schema:givenName Antonio
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01207036636.03
216 rdf:type schema:Person
217 sg:person.01226564066.51 schema:affiliation https://www.grid.ac/institutes/grid.418321.d
218 schema:familyName Buonadonna
219 schema:givenName Angela
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01226564066.51
221 rdf:type schema:Person
222 sg:person.01251771615.34 schema:affiliation N888d1069721a491bb8ffd2281115ce95
223 schema:familyName Bichisao
224 schema:givenName Ettore
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01251771615.34
226 rdf:type schema:Person
227 sg:person.01270617624.45 schema:affiliation https://www.grid.ac/institutes/grid.417893.0
228 schema:familyName Celio
229 schema:givenName Luigi
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01270617624.45
231 rdf:type schema:Person
232 sg:person.01313436706.49 schema:affiliation https://www.grid.ac/institutes/grid.418322.e
233 schema:familyName Capobianco
234 schema:givenName Alba Maria
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01313436706.49
236 rdf:type schema:Person
237 sg:person.01323422756.41 schema:affiliation Nf0c0e5f099a344b698b97dd8c33d6b72
238 schema:familyName Isa
239 schema:givenName Luciano
240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01323422756.41
241 rdf:type schema:Person
242 sg:person.01336710567.12 schema:affiliation https://www.grid.ac/institutes/grid.144767.7
243 schema:familyName Piazza
244 schema:givenName Elena
245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01336710567.12
246 rdf:type schema:Person
247 sg:person.0635337452.63 schema:affiliation https://www.grid.ac/institutes/grid.417520.5
248 schema:familyName Fabi
249 schema:givenName Alessandra
250 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0635337452.63
251 rdf:type schema:Person
252 sg:person.0636427656.94 schema:affiliation Nf59eb66b3c814c0a8957de869ccbdce1
253 schema:familyName Bertolini
254 schema:givenName Alessandro
255 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0636427656.94
256 rdf:type schema:Person
257 sg:person.0652421767.09 schema:affiliation https://www.grid.ac/institutes/grid.418321.d
258 schema:familyName Frustaci
259 schema:givenName Sergio
260 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0652421767.09
261 rdf:type schema:Person
262 sg:person.0771775231.11 schema:affiliation N7f11b1a5a9e84e3994180ec368832fae
263 schema:familyName Cavanna
264 schema:givenName Luigi
265 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0771775231.11
266 rdf:type schema:Person
267 sg:pub.10.1007/s00520-004-0700-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008308814
268 https://doi.org/10.1007/s00520-004-0700-8
269 rdf:type schema:CreativeWork
270 sg:pub.10.1007/s00520-008-0535-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015303642
271 https://doi.org/10.1007/s00520-008-0535-9
272 rdf:type schema:CreativeWork
273 sg:pub.10.1038/sj.bjc.6603048 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030164430
274 https://doi.org/10.1038/sj.bjc.6603048
275 rdf:type schema:CreativeWork
276 sg:pub.10.2165/00003495-200464100-00006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037955349
277 https://doi.org/10.2165/00003495-200464100-00006
278 rdf:type schema:CreativeWork
279 https://app.dimensions.ai/details/publication/pub.1077302236 schema:CreativeWork
280 https://app.dimensions.ai/details/publication/pub.1077317669 schema:CreativeWork
281 https://doi.org/10.1002/cncr.11817 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010335838
282 rdf:type schema:CreativeWork
283 https://doi.org/10.1016/j.ejcsup.2008.06.018 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037546665
284 rdf:type schema:CreativeWork
285 https://doi.org/10.1016/s1470-2045(05)01735-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034367406
286 rdf:type schema:CreativeWork
287 https://doi.org/10.1056/nejmra0706547 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047566735
288 rdf:type schema:CreativeWork
289 https://doi.org/10.1093/annonc/mdg417 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047729604
290 rdf:type schema:CreativeWork
291 https://doi.org/10.1093/annonc/mdj078 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011961022
292 rdf:type schema:CreativeWork
293 https://doi.org/10.1093/annonc/mdj936 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001372120
294 rdf:type schema:CreativeWork
295 https://doi.org/10.1093/annonc/mdj944 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002400172
296 rdf:type schema:CreativeWork
297 https://doi.org/10.1093/annonc/mdl347 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037286350
298 rdf:type schema:CreativeWork
299 https://doi.org/10.1093/annonc/mdp584 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007050927
300 rdf:type schema:CreativeWork
301 https://doi.org/10.1200/jco.1997.15.1.103 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083031468
302 rdf:type schema:CreativeWork
303 https://doi.org/10.1200/jco.2000.18.19.3409 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074706771
304 rdf:type schema:CreativeWork
305 https://doi.org/10.1200/jco.2005.04.022 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043661291
306 rdf:type schema:CreativeWork
307 https://doi.org/10.1200/jco.2005.09.050 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031033192
308 rdf:type schema:CreativeWork
309 https://doi.org/10.1200/jco.2007.15.9533 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010850821
310 rdf:type schema:CreativeWork
311 https://doi.org/10.1213/ane.0b013e318172fa74 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051586456
312 rdf:type schema:CreativeWork
313 https://www.grid.ac/institutes/grid.144767.7 schema:alternateName Luigi Sacco Hospital
314 schema:name Ospedale L. Sacco, Via Grassi 74, 20157 Milan, Italy
315 rdf:type schema:Organization
316 https://www.grid.ac/institutes/grid.415025.7 schema:alternateName Azienda Ospedaliera San Gerardo
317 schema:name Ospedale San Gerardo, Via Pergolesi 33, 20052 Monza, Italy
318 rdf:type schema:Organization
319 https://www.grid.ac/institutes/grid.417520.5 schema:alternateName Istituti Fisioterapici Ospitalieri
320 schema:name Istituto Regina Elena, Via Chianesi 53, 00144 Rome, Italy
321 rdf:type schema:Organization
322 https://www.grid.ac/institutes/grid.417893.0 schema:alternateName Istituto Nazionale dei Tumori
323 schema:name Medical Oncology Unit 2, Fondazione IRCCS “Istituto Nazionale dei Tumori”, Via Venezian 1, 20133 Milan, Italy
324 rdf:type schema:Organization
325 https://www.grid.ac/institutes/grid.418321.d schema:alternateName Centro di Riferimento Oncologico
326 schema:name Centro di Riferimento Oncologico, Via Gallini 2, 33081 Aviano, Italy
327 rdf:type schema:Organization
328 https://www.grid.ac/institutes/grid.418322.e schema:alternateName Centro di Riferimento Oncologico della Basilicata
329 schema:name Centro Riferimento Oncologico della Basilicata, Strada Provinciale n. 8 del Vulture, 85028 Rionero in Vulture, Italy
330 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...